What is the current valuation of the India sleeping bruxism-treatment market?

The market valuation was $24.67 Million in 2024. Read More

What is the projected market size for the India sleeping bruxism-treatment market by 2035?

The market is projected to reach $49.21 Million by 2035. Read More

What is the expected CAGR for the India sleeping bruxism-treatment market during the forecast period 2025 - 2035?

The expected CAGR is 6.48% during the forecast period. Read More

Which companies are the key players in the India sleeping bruxism-treatment market?

Key players include Procter & Gamble, GlaxoSmithKline, Johnson & Johnson, and Colgate-Palmolive. Read More

What are the primary and secondary bruxism market segments valued at?

Primary bruxism is valued between $10.0 Million and $20.0 Million, while secondary bruxism ranges from $14.67 Million to $29.21 Million. Read More

What causes are associated with the India sleeping bruxism-treatment market?

Causes include obstructive sleep apnea, gastroesophageal reflux disease (GERD), malocclusion, and sleep paralysis. Read More

What treatment options are available in the India sleeping bruxism-treatment market?

Treatment options include dental approaches, mouth guards, NTI-TSS devices, medication, muscle relaxants, botulinum toxin type A injections, and anti-anxiety drugs. Read More

How is the patient demographic segmented in the India sleeping bruxism-treatment market?

The patient demographic is segmented into pediatric, adult, male, and female categories. Read More

What are the end-user segments in the India sleeping bruxism-treatment market?

End-user segments include hospitals & clinics and dental clinics. Read More

What is the significance of the dental clinics segment in the market?

The dental clinics segment is valued between $14.67 Million and $29.21 Million, indicating its substantial role in the market. Read More

India Sleeping Bruxism Treatment Market

ID: MRFR/HC/47743-HCR

200 Pages

Vikita Thakur

Last Updated: April 06, 2026

India Sleeping Bruxism Treatment Market Research Report By Type (Primary Bruxism, Secondary Bruxism), By Treatment (Dental Approaches, Medication), By Cause (Obstructive Sleep Apnea, Gastroesophageal Reflux Disease, Malocclusion, Sleep Paralysis), By Patient Type (Pediatric, Adult) and By End User (Hospitals & Clinics, Dental Clinics) - Growth & Industry Forecast 2025 To 2035

India Sleeping Bruxism Treatment Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Type (USD Million)
  1. 4.1.1 Primary Bruxism
  2. 4.1.2 Secondary Bruxism
2. 4.2 Life Sciences, BY Cause (USD Million)
  1. 4.2.1 Obstructive Sleep Apnea
  2. 4.2.2 Gastroesophageal Reflux Disease (GERD)
  3. 4.2.3 Malocclusion
  4. 4.2.4 Sleep Paralysis
3. 4.3 Life Sciences, BY Treatment (USD Million)
  1. 4.3.1 Dental Approaches
  2. 4.3.2 Mouth Guard
  3. 4.3.3 NTI-TSS Device
  4. 4.3.4 Medication
  5. 4.3.5 Muscle Relaxants
  6. 4.3.6 Botulinum toxin type A Injections
  7. 4.3.7 Anti-anxiety Drugs
4. 4.4 Life Sciences, BY Patient Type (USD Million)
  1. 4.4.1 Pediatric
  2. 4.4.2 Adult
  3. 4.4.3 Male
  4. 4.4.4 Female
5. 4.5 Life Sciences, BY End User (USD Million)
  1. 4.5.1 Hospitals & Clinics
  2. 4.5.2 Dental Clinics
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Procter & Gamble (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 GlaxoSmithKline (GB)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Colgate-Palmolive (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Dentsply Sirona (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 3M (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Kavo Kerr (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Oral-B (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY TYPE
3. 6.3 INDIA MARKET ANALYSIS BY CAUSE
4. 6.4 INDIA MARKET ANALYSIS BY TREATMENT
5. 6.5 INDIA MARKET ANALYSIS BY PATIENT TYPE
6. 6.6 INDIA MARKET ANALYSIS BY END USER
7. 6.7 KEY BUYING CRITERIA OF LIFE SCIENCES
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF LIFE SCIENCES
10. 6.10 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
12. 6.12 SUPPLY / VALUE CHAIN: LIFE SCIENCES
13. 6.13 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
14. 6.14 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 LIFE SCIENCES, BY CAUSE, 2024 (% SHARE)
16. 6.16 LIFE SCIENCES, BY CAUSE, 2024 TO 2035 (USD Million)
17. 6.17 LIFE SCIENCES, BY TREATMENT, 2024 (% SHARE)
18. 6.18 LIFE SCIENCES, BY TREATMENT, 2024 TO 2035 (USD Million)
19. 6.19 LIFE SCIENCES, BY PATIENT TYPE, 2024 (% SHARE)
20. 6.20 LIFE SCIENCES, BY PATIENT TYPE, 2024 TO 2035 (USD Million)
21. 6.21 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
22. 6.22 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY CAUSE, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
  4. 7.2.4 BY PATIENT TYPE, 2025-2035 (USD Million)
  5. 7.2.5 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Life Sciences Market Segmentation

Life Sciences By Type (USD Million, 2025-2035)

Primary Bruxism
Secondary Bruxism

Life Sciences By Cause (USD Million, 2025-2035)

Obstructive Sleep Apnea
Gastroesophageal Reflux Disease (GERD)
Malocclusion
Sleep Paralysis

Life Sciences By Treatment (USD Million, 2025-2035)

Dental Approaches
Mouth Guard
NTI-TSS Device
Medication
Muscle Relaxants
Botulinum toxin type A Injections
Anti-anxiety Drugs

Life Sciences By Patient Type (USD Million, 2025-2035)

Pediatric
Adult
Male
Female

Life Sciences By End User (USD Million, 2025-2035)

Hospitals & Clinics
Dental Clinics

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”